Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Late phase II weekly paclitaxel in advanced head and neck cancer
jRCT2080220194Phase 2
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in head and neck cancer (HNC), sponsored by Bristol Myers Squibb.
02
Drugs
paclitaxel
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on jRCT2080220194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220194.